These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35396884)

  • 1. Changing Fate: Reprogramming Cells via Engineered Nanoscale Delivery Materials.
    Soltani Dehnavi S; Eivazi Zadeh Z; Harvey AR; Voelcker NH; Parish CL; Williams RJ; Elnathan R; Nisbet DR
    Adv Mater; 2022 Aug; 34(33):e2108757. PubMed ID: 35396884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming.
    Fang J; Hsueh YY; Soto J; Sun W; Wang J; Gu Z; Khademhosseini A; Li S
    ACS Nano; 2020 Feb; 14(2):1296-1318. PubMed ID: 32011856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Micro- and Nanoscale Materials in Cell-Engineering Systems.
    Jiang Y; Harberts J; Assadi A; Chen Y; Spatz JP; Duan W; Nisbet DR; Voelcker NH; Elnathan R
    Adv Mater; 2024 Oct; ():e2410908. PubMed ID: 39401098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Technologies To Enhance In Vivo Reprogramming for Regenerative Medicine.
    Larouche J; Aguilar CA
    Trends Biotechnol; 2019 Jun; 37(6):604-617. PubMed ID: 30527703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
    Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
    Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
    Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
    Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology in regenerative ophthalmology.
    Sahle FF; Kim S; Niloy KK; Tahia F; Fili CV; Cooper E; Hamilton DJ; Lowe TL
    Adv Drug Deliv Rev; 2019 Aug; 148():290-307. PubMed ID: 31707052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology-based drug delivery systems in orthopedics.
    Güven E
    Jt Dis Relat Surg; 2021; 32(1):267-273. PubMed ID: 33463450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials for regenerative medicine.
    Verma S; Domb AJ; Kumar N
    Nanomedicine (Lond); 2011 Jan; 6(1):157-81. PubMed ID: 21182426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications.
    La Francesca S
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):28-35. PubMed ID: 22891108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in Self-assembling Peptide-based Nanomaterials for Biomedical Applications.
    Yu CY; Huang W; Li ZP; Lei XY; He DX; Sun L
    Curr Top Med Chem; 2016; 16(3):281-90. PubMed ID: 26126914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of emerging nanotechnology in bone regeneration: progress, challenges, and perspectives.
    Hajiali H; Ouyang L; Llopis-Hernandez V; Dobre O; Rose FRAJ
    Nanoscale; 2021 Jun; 13(23):10266-10280. PubMed ID: 34085085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonviral delivery for reprogramming to pluripotency and differentiation.
    Park HJ; Shin J; Kim J; Cho SW
    Arch Pharm Res; 2014 Jan; 37(1):107-19. PubMed ID: 24222505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale surfacing for regenerative medicine.
    Yang Y; Leong KW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):478-95. PubMed ID: 20803682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: the applications of nanotechnology in gastroenterology.
    Brakmane G; Winslet M; Seifalian AM
    Aliment Pharmacol Ther; 2012 Aug; 36(3):213-21. PubMed ID: 22686286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative nanomedicine: current perspectives and future directions.
    Chaudhury K; Kumar V; Kandasamy J; RoyChoudhury S
    Int J Nanomedicine; 2014; 9():4153-67. PubMed ID: 25214780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of nanostructured materials on biointerfacial interactions.
    Koegler P; Clayton A; Thissen H; Santos GN; Kingshott P
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1820-39. PubMed ID: 22705547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers.
    Gallego-Perez D; Otero JJ; Czeisler C; Ma J; Ortiz C; Gygli P; Catacutan FP; Gokozan HN; Cowgill A; Sherwood T; Ghatak S; Malkoc V; Zhao X; Liao WC; Gnyawali S; Wang X; Adler AF; Leong K; Wulff B; Wilgus TA; Askwith C; Khanna S; Rink C; Sen CK; Lee LJ
    Nanomedicine; 2016 Feb; 12(2):399-409. PubMed ID: 26711960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.